Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-06 · 43 (6)
DOI: 10.1161/atvbaha.122.318725 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-06. Verfasst von Bom Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, South Korea (B.L.,…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Drug-Eluting Stents, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
We sought to explore the sex differences in clinical outcomes among patients with acute coronary syndrome treated with ticagrelor monotherapy after ticagrelor-based 3-month versus 12-month dual-antiplatelet therapy.
Methods
This was a post hoc analysis of the TICO trial (Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus-Eluting Stent for Acute Coronary Syndrome; n=3056)—a randomized controlled trial for patients with acute coronary syndrome treated with drug-eluting stent. The primary outcome was a net adverse clinical event (composite of major bleeding, death, myocardial infarction, stent thrombosis, stroke, or target-vessel revascularization) 1 year after drug-eluting stent implantation. Secondary outcomes included major bleeding and major adverse cardiac and cerebrovascular events.
Results
There were 27.3% (n=628) women in the TICO trial; they were older with lower body mass index and higher prevalence of hypertension, diabetes, or chronic kidney disease than men. Compared with men, women had higher risk of net adverse clinical events (hazard ratio [HR], 1.89 [95% CI, 1.34–2.67]), major adverse cardiac and cerebrovascular events (HR, 1.69 [95% CI, 1.07–2.68]), and major bleeding (HR, 2.04 [95% CI, 1.25–3.35]). Among the groups stratified by sex and dual-antiplatelet therapy strategy, the incidences of primary and secondary outcomes were significantly different and the highest in women with ticagrelor-based 12-month dual-antiplatelet therapy ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, South Korea (B.L., Y.J.).
- Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea (S.-J.L., B.-K.K., Y.-J.L., S.-J.H., C.-M.A., J.-S.K., Y.-G.K., D.C.,…
ORCID-Profile: Seung-Jun Lee, Byeong-Keuk Kim, Yong-Joon Lee, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Meyong-Ki Hong, Yangsoo Jang
Zitieren
APA
Lee, B., Lee, S. J., Kim, B. K., Lee, Y. J., Hong, S. J., Ahn, C. M., Kim, J. S., Ko, Y. G., Choi, D., Hong, M. K., & Jang, Y. (2023). Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(6). https://doi.org/10.1161/atvbaha.122.318725
Vancouver
Lee B, Lee SJ, Kim BK, Lee YJ, Hong SJ, Ahn CM, et al. Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(6). doi:10.1161/atvbaha.122.318725
BibTeX
@article{Lee2023,
author = {Lee, Bom and Lee, Seung-Jun and Kim, Byeong-Keuk and Lee, Yong-Joon and Hong, Sung-Jin and Ahn, Chul-Min and Kim, Jung-Sun and Ko, Young-Guk and Choi, Donghoon and Hong, Meyong-Ki and Jang, Yangsoo},
title = {Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
volume = {43},
number = {6},
doi = {10.1161/atvbaha.122.318725}
}
EUVIMED